Acta obstetricia et gynecologica Scandinavica
-
Acta Obstet Gynecol Scand · Oct 2012
Serum soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy prior to clinical onset of preeclampsia.
To examine whether soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy could be a risk marker for later development of preeclampsia. ⋯ suPAR did not appear to be a useful early pre-clinical marker of preeclampsia.